Descriptor English: | Histamine H1 Antagonists, Non-Sedating | ||||||
Descriptor Spanish: |
Antagonistas de los Receptores Histamínicos H1 no Sedantes
| ||||||
Descriptor Portuguese: | Antagonistas não Sedativos dos Receptores H1 da Histamina | ||||||
Descriptor French: | Antihistaminiques H1 non sédatifs | ||||||
Entry term(s): |
Antihistamine, Second Generation Antihistamines, Second Generation Generation Antihistamine, Second H1 Antihistamines, Non Sedating H1 Antihistamines, Non-Sedating Histamine H1 Antagonists, Non Sedating Non-Sedating H1 Antihistamines Second Generation Antihistamine Second Generation Antihistamines Second Generation H1 Antagonist Second Generation H1 Antagonists Third Generation H1 Antagonist Third Generation H1 Antagonists |
||||||
Tree number(s): |
D27.505.519.625.375.425.400.500 D27.505.696.577.375.425.400.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D039563 | ||||||
Scope note: | A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Previous Indexing: |
Benzhydryl Compounds (1982-2002) Histamine H1 Antagonists (1982-2002) |
||||||
Public MeSH Note: | 2003 |
||||||
History Note: | 2003 |
||||||
Entry Version: | HISTAMINE H1 ANTAG NON SEDATING |
||||||
Related: |
Anti-Allergic Agents
MeSH | ||||||
DeCS ID: | 37547 | ||||||
Unique ID: | D039563 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2003/01/01 | ||||||
Date of Entry: | 2002/07/02 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses -
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
Histamine H1 Antagonists, Non-Sedating
- Preferred
Third Generation H1 Antagonists
- Narrower
Concept UI |
M0419330 |
Scope note | A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. |
Preferred term | Histamine H1 Antagonists, Non-Sedating |
Entry term(s) |
Antihistamine, Second Generation Antihistamines, Second Generation Generation Antihistamine, Second H1 Antihistamines, Non Sedating H1 Antihistamines, Non-Sedating Histamine H1 Antagonists, Non Sedating Non-Sedating H1 Antihistamines Second Generation Antihistamine Second Generation Antihistamines Second Generation H1 Antagonist Second Generation H1 Antagonists |
Concept UI |
M0503955 |
Scope note | Active enantiomers and selective derivatives of second generation H1 antagonists. |
Preferred term | Third Generation H1 Antagonists |
Entry term(s) |
Third Generation H1 Antagonist |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey